RYTHM (RYM) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Develops branded consumer-packaged goods for the cannabis and hemp industries, with a focus on hemp-derived THC beverages and intellectual property licensing for cannabis brands.
Señorita brand offers low-sugar, low-calorie hemp-derived THC cocktails, distributed in 11 U.S. states and Canada, with direct-to-consumer sales where permitted.
Acquired multiple cannabis and hemp-related brands and associated IP from Green Thumb Industries in 2025, entering into royalty and licensing agreements.
Exited cultivation and extraction equipment businesses in late 2024 and early 2025 to focus on consumer brands and IP.
Utilizes third-party co-manufacturers and distribution agreements to expand product reach and minimize supply chain risks.
Financial performance and metrics
As of October 8, 2025, public float was approximately $60.3 million, with 1,249,656 shares held by non-affiliates at $48.25 per share.
Outstanding common stock totaled 2,002,568 shares, with significant warrants and convertible notes outstanding.
Issued $90 million in secured convertible notes between November 2024 and August 2025, with conversion prices ranging from $3.158 to $29.475.
Qualifies as a smaller reporting company, providing reduced disclosure and exempt from certain Sarbanes-Oxley requirements.
Use of proceeds and capital allocation
Proceeds intended for working capital and general corporate purposes, with potential for acquisitions or strategic investments.
No specific allocation of proceeds; management has broad discretion over use.
Pending use, proceeds will be invested in short-term, investment-grade instruments and U.S. government securities.
Latest events from RYTHM
- Q4 revenue up 164% with 75% gross margin; regulatory risks persist for hemp-derived THC.RYM
Q4 20253 Mar 2026 - Regulatory changes threaten the future of a $100M hemp-THC brand offering.RYM
Registration Filing16 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and equity plan amendment.RYM
Proxy Filing1 Dec 2025 - Key votes include director elections, reverse stock split, and equity plan expansion.RYM
Proxy Filing1 Dec 2025 - Key votes include director elections, reverse stock split, and major equity plan amendments.RYM
Proxy Filing1 Dec 2025 - Quorum for the August 2024 Annual Meeting is now one-third of outstanding shares.RYM
Proxy Filing1 Dec 2025 - Equity line offering seeks up to $15M amid financial challenges and industry risks.RYM
Registration Filing29 Nov 2025 - Registering 4.7M shares for resale to raise up to $15M amid ongoing losses and dilution risk.RYM
Registration Filing28 Nov 2025 - Q3 2025 revenue hit $4.0M, nearly doubling sequentially as THC beverages expanded in retail.RYM
Q3 20257 Nov 2025